anagrelide
NDC 13668-453, anagrelide, capsule, from Torrent Pharmaceuticals Limited.
- Product NDC
- 13668-453
- Status
- Listed
- Labeler
- Torrent Pharmaceuticals Limited
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209151
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/13668-453 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ANAGRELIDE HYDROCHLORIDE ANHYDROUS.5 mg/1
Pharmacologic classes
Decreased Platelet Production [PE]; Phosphodiesterase 3 Inhibitors [MoA]; Platelet-reducing Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 13668-453-01 | 13668045301 | 100 CAPSULE in 1 BOTTLE (13668-453-01) |
| 13668-453-30 | 13668045330 | 30 CAPSULE in 1 BOTTLE (13668-453-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/875cc32a-219c-4b6b-802a-98a47cbc9a78NADAC price for package 13668045301
GET /v1/drugs/nadac/13668045301
Use it
Look up 13668-453 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/13668-453 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 13668-453. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.